The 0.05% trim by Dodge & Cox is a routine rebalancing move, not a conviction change. Monitor the next 13F filing for the full Q2 2026 position size. No immediate trading action warranted.
Price Chart
Executive Summary
Dodge & Cox, a top-3 institutional holder of GSK, disclosed a reduction in its voting rights stake from 5.01% to 4.96%, crossing below the 5% UK notification threshold. The sale of approximately 2 million shares (based on the 0.05% decline) is a modest trim by a long-term value manager, not a material bearish signal for a $107B pharma company.
Key Facts
- Dodge & Cox reduced its GSK voting rights stake from 5.01% to 4.96%, crossing below the 5% threshold on June 24, 2026.
- Total voting rights held: 201,065,668 (4.96% of total), split between ordinary shares (88,816,040; 2.19%) and ADRs (112,249,628; 2.77%).
- No financial instruments (options, swaps, etc.) were reported — the entire position is in common equity.
- Dodge & Cox remains a top-3 institutional holder per the 13F snapshot ($3.2B position as of Q1 2026).
Financial Impact
Stake reduction of ~0.05% of total voting rights, representing roughly 2 million shares or ~$80-100M at current prices — a routine portfolio trim for a $3.2B position.
Risk Factors
- Further selling by Dodge & Cox could signal reduced conviction, but the current 0.05% reduction is immaterial.
- The 20-F annual report (filed 115 days ago) provides the broader financial context — no recent earnings or guidance updates are available in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-006269 |
| Document: 0001654954-26-006269-index-headers.html | 0001654954-26-006269 |
| Document: 0001654954-26-006269-index.html | 0001654954-26-006269 |
| Document: 0001654954-26-006269.txt | 0001654954-26-006269 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $50.01 $50.22 | ▲ +0.42% | ▼ −0.40% | $47.03 (−5.96%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 11, 2026 21d ago | 6-K | $48.13 $50.22 | ▲ +4.34% | ▲ +4.56% | $47.03 (−2.29%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Aug 26, 2026 5w ago | 6-K | $51.43 $50.44 | ▼ −1.92% | ▼ −1.80% | $47.03 (−8.56%) |
Aug 24, 2026 5w ago | 6-K | $51.78 $50.25 | ▼ −2.95% | ▼ −3.42% | $47.03 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access